2020
DOI: 10.1007/s12350-019-01661-8
|View full text |Cite|
|
Sign up to set email alerts
|

Risk stratification with vasodilator stress SPECT myocardial perfusion imaging in patients with elevated cardiac biomarkers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 27 publications
0
1
0
Order By: Relevance
“…In this issue of the Journal, Gowdar et al 11 provide an important addition to the body of evidence validating SPECT MPI as a prognostic tool with incremental value to clinical and laboratory data. This retrospective cohort study in two tertiary medical centers evaluated the early use of regadenoson SPECT MPI for risk stratification in patients with elevated troponin after MI or in patients with troponin elevation of unclear etiology.…”
Section: See Related Article Pp 2320-2331mentioning
confidence: 99%
“…In this issue of the Journal, Gowdar et al 11 provide an important addition to the body of evidence validating SPECT MPI as a prognostic tool with incremental value to clinical and laboratory data. This retrospective cohort study in two tertiary medical centers evaluated the early use of regadenoson SPECT MPI for risk stratification in patients with elevated troponin after MI or in patients with troponin elevation of unclear etiology.…”
Section: See Related Article Pp 2320-2331mentioning
confidence: 99%